|
|
Article: Human Genome Sciences licenses human gene technology to Genentech.(Brief Article)
- Article from:
- BIOTECH Patent News
- Article date:
- August 1, 2003
CopyrightCOPYRIGHT 2003 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Human Genome Sciences, Inc. (Rockville, MD) formed a license agreement with Genentech, Inc. (S. San Francisco, CA) under which Genentech has acquired exclusive, worldwide patent rights to develop and commercialize therapeutic biologic products for human use based on a human gene discovered by Human Genome Sciences that may have potential applications in immunology, oncology and neurology. Under the agreement, Genentech also has acquired non-exclusive, worldwide rights for the development and commercialization of diagnostic and small molecule products for human use based on the same gene.
According to the terms of the agreement, Human Genome Sciences will receive ...
Related newspaper, magazine, and journal articles:
|
|
Article: Cambridge Antibody Technology and Human Genome ...
PR Newswire;
January 8, 2002 ;
700+ words
... ... Cambridge Antibody Technology and Human Genome Sciences, Inc. today announce that Human Genome Sciences has exercised an option to enter into ... evaluated as an anti-cancer drug by Human Genome Sciences. TRAIL Receptor 1, which was discovered ...
|
|